Review IDs Care Gaps for Teens With Chronic Conditions

Share this content:
Review IDs Care Gaps for Teens With Chronic Conditions
Review IDs Care Gaps for Teens With Chronic Conditions

TUESDAY, March 8, 2016 (HealthDay News) -- Patient-related determinants of care gaps have been identified in adolescents with chronic conditions; the findings were published online March 3 in Pediatrics.

Eva Goossens, Ph.D., R.N., from the KU University of Leuven in Belgium, and colleagues conducted a systematic review to examine determinants of care gaps in young people with chronic conditions as they transition to adulthood. Ten publications that discussed care gaps in patients aged 10 to 25 years were reviewed. Using thematic analysis, determinants were categorized into four groups.

The researchers identified 11 risk factors and nine protective factors for care gaps, all of which were related to patient characteristics. Significant determinants of care gaps in adolescents with chronic conditions were demographics, disease-related characteristics, health care service use, and patient health behaviors and beliefs.

"This systematic review identified patient-related determinants of care gaps," the authors write. "Unfortunately, the internal and external validity of the study findings are limited, warranting future prospective, multilevel studies that address remaining knowledge gaps."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths